HeartBeam Ranked Second Globally in 12-Lead ECG Innovation by PatentVest Report

HeartBeam Inc. (NASDAQ: BEAT) has been recognized as a Global IP and Technology Leader in Portable Cardiac Diagnostics by PatentVest's 'Total Cardiac Intelligence' report available at https://ibn.fm/ZuLCr. The medical-technology company developing advanced electrocardiogram solutions for remote cardiac care ranked second worldwide in 12-lead ECG innovation among 243 firms analyzed, trailing only GE Healthcare. This recognition highlights HeartBeam's growing influence in the next generation of cardiac monitoring technology and underscores the company's position as a significant player in the evolving landscape of remote healthcare solutions.

The company's intellectual-property foundation is a major reason for its high placement in the global rankings. HeartBeam's ranking underscores the rapid maturation of the company's proprietary synthesis-ECG system, which captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG. This unique approach allows physicians to obtain comprehensive cardiac data through portable technology, potentially transforming how cardiac conditions are monitored and diagnosed outside traditional clinical settings. The technology represents a significant advancement in making sophisticated cardiac diagnostics more accessible to patients in various environments.

The HeartBeam System is a portable non-invasive recorder intended to record, store, and transfer a patient's 3-Lead electrocardiogram acquired from 5 electrodes. The device is designed to be used by adult patients in either a clinical setting or at home, providing flexibility in cardiac monitoring that aligns with the growing trend toward remote healthcare. While the device does not conduct cardiac analysis itself, it can be used with an ECG Viewer software system for manual interpretation of non-life-threatening arrhythmias by physicians or healthcare professionals. This combination of portability and clinical utility positions HeartBeam's technology at the forefront of innovation in cardiac care diagnostics.

The recognition by PatentVest's comprehensive evaluation of 243 companies worldwide validates HeartBeam's technological approach and intellectual property strategy. Being ranked second globally, just behind industry giant GE Healthcare, demonstrates the company's competitive standing in the medical technology sector. This achievement comes at a time when remote patient monitoring and portable diagnostic technologies are gaining increased importance in healthcare systems worldwide. The company's focus on developing solutions that bridge the gap between clinical-grade diagnostics and patient convenience addresses a critical need in modern healthcare delivery, particularly as telemedicine and remote monitoring continue to expand their roles in patient care.